Lithium Carbonate 99.5+%

Referencia 239545-5Kg

embalaje : 5Kg

Marca : US Biological

Contact local distributor :


Teléfono : +1 850 650 7790


239545 Lithium Carbonate 99.5+%

Grade
Highly Purified
Shipping Temp
RT
Storage Temp
RT

A neuroprotective effect of lithium carbonate in amyotrophic lateral sclerosis (ALS). Dyes and metabolites. Lithium carbonate has been used in psychiatry since the 1950's to treat mania and depressive disorders. It is an element with a positive charge similar to sodium and potassium. In cells, lithium interferes with other positively charged atoms important to many cellular functions. It interferes with neurotransmitter production and uptake. Current biological studies are looking into lithium treatment for additional CNS disorders such as Alzheimer's disease.

Synonyms:
Carbonic Acid Lithium Salt; Carbonic Acid Dilithium Salt; CP 15467-61; Camcolit; Candamide; Carbolith; Carbolithium; Carbonic Acid Lithium Salt; Ceglution; Dilithium Carbonate; Eskalith; Hypnorex; Limas; Liskonum; Lithane; Lithicarb; Lithobid; Lithocarb; Lithonate; Lithotabs; Micalith; NSC 16895; Phasal; Plenur; Priadel; Quilonorm-retard; Quilonum Retard; Teralithe

CAS No:
554-13-2
Free Acid 463-79-6

Molecular Formula:
Li2CO3

Molecular Weight:
73.89

Appearance:
White solid

Purity:
≥99.5%

Melting Point:
As reported

pH:
9-11 (1g/L)

Water (KF):
≤0.4%

Sulfate (SO42-):
≤0.07%

Chloride (Cl-):
≤0.005%

Sodium (Na):
≤0.05%

Potassium (K):
≤0.005%

Magnesium (Mg):
0.003%

Calcium (Ca):
≤ 0.005%

Aluminum (Al):
≤0.002%

Iron (Fe):
≤0.001%

Solubility:
Water

Storage and Stability:
May be stored at RT.

Applications
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. Toxicity and Hazards: All products should be handled by qualified personnel only, trained in laboratory procedures.
Form
White solid
Purity
≥99.5%
References
1. Grandjean, E.M. and Aubry, J.M. 2009. CNS Drugs. 23: 331-349. PMID: 19374461|2. Leroy, K., et al. 2009. J. Alzheimers Dis. PMID: 19920318|3. Leroy, K., et al. 2010. J. Alzheimers Dis. 19: 705-719. PMID: 20110614|4. Gordon, P., et al.: Lancet Neurol., 6, 1045 ( 2007)|5. Shin, J., et al.: Mol. Pharmacol., 71, 965 (2007)|6. Chio, A., et al.: Amyotroph. Lateral Scler., 10, 310 (2009)